Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Anesth Analg. 2004 Jun;98(6):1635-9, table of contents.

Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia.

Author information

  • 1Department of Anesthesia and Perioperative Care, University of California at San Francisco, Mailbox 0464, Room U 368 P, Moffitt Hospital, 513 Parnassus Avenue, San Francisco, CA 94143, USA. gstratmann@anesthesia.ucsf.edu

Abstract

We treated persistent hemorrhage after cardiopulmonary bypass in a heart transplant recipient who had received anticoagulation with the direct thrombin inhibitor bivalirudin by a combination therapy aimed at reducing the plasma concentration of the thrombin antagonist (hemodialysis and modified ultrafiltration), increasing the concentration of thrombin at bleeding sites (recombinant factor VIIa), and increasing the plasma concentration of other coagulation factors (fresh frozen plasma and cryoprecipitate). The bleeding was controlled, and there was no thrombotic complication.

IMPLICATIONS:

A combination of modified ultrafiltration, hemodialysis, and the administration of recombinant factor VIIa, fresh frozen plasma, and cryoprecipitate may reverse the anticoagulant effect of bivalirudin.

PMID:
15155316
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk